<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107-vaccines-07-00053">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gowen</surname>
    <given-names>B.B.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>K.H.</given-names>
   </name>
   <name>
    <surname>Sanders</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Mendenhall</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bailey</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Furuta</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sidwell</surname>
    <given-names>R.W.</given-names>
   </name>
  </person-group>
  <article-title>In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2007</year>
  <volume>51</volume>
  <fpage>3168</fpage>
  <lpage>3176</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00356-07</pub-id>
  <?supplied-pmid 17606691?>
  <pub-id pub-id-type="pmid">17606691</pub-id>
 </element-citation>
</ref>
